LEABETH PACK: Open Payments
NPI 1154747889 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,563 in 67 payments from 15 companies in 2025. Trend: 2023 $798 · 2024 $1,454 · 2025 $1,563
Food & beverage: $1,563
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $384 |
| Corcept Therapeutics | 9 | $283 |
| Lilly USA, LLC | 5 | $195 |
| Novo Nordisk Inc | 9 | $171 |
| AstraZeneca Pharmaceuticals LP | 7 | $138 |
| Xeris Pharmaceuticals, Inc. | 4 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $65 |
| Antares Pharma, Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Inspire Medical Systems, Inc. | 1 | $33 |
Products named: Korlym, QULIPTA, ZEPBOUND, UBRELVY, VRAYLAR, GVOKE HYPOPEN, BREZTRI, AIRSUPRA.
Industry payments across TN — which companies pay providers there.
